van Rooij, Sanne J. H. http://orcid.org/0000-0002-0160-7248
Santos, Justin L.
Hinojosa, Cecilia A.
Ely, Timothy D. http://orcid.org/0000-0002-5690-5234
Harnett, Nathaniel G. http://orcid.org/0000-0001-5346-2012
Murty, Vishnu P.
Lebois, Lauren A. M. http://orcid.org/0000-0001-5816-9181
Jovanovic, Tanja
House, Stacey L.
Bruce, Steven E. http://orcid.org/0000-0002-5807-4382
Beaudoin, Francesca L.
An, Xinming
Neylan, Thomas C. http://orcid.org/0000-0002-1572-2626
Clifford, Gari D.
Linnstaedt, Sarah D. http://orcid.org/0000-0001-5295-7072
Germine, Laura T. http://orcid.org/0000-0001-8690-8412
Bollen, Kenneth A.
Rauch, Scott L.
Haran, John P. http://orcid.org/0000-0001-7311-1121
Storrow, Alan B. http://orcid.org/0000-0002-2893-808X
Lewandowski, Christopher http://orcid.org/0000-0001-8297-0024
Musey, Paul I. Jr. http://orcid.org/0000-0002-5693-190X
Hendry, Phyllis L.
Sheikh, Sophia http://orcid.org/0000-0003-1939-3126
Jones, Christopher W.
Punches, Brittany E. http://orcid.org/0000-0002-7546-1966
Swor, Robert A.
Pascual, Jose L. http://orcid.org/0000-0002-1613-7912
Seamon, Mark J.
Harris, Erica
Pearson, Claire
Peak, David A.
Merchant, Roland C.
Domeier, Robert M.
Rathlev, Niels K.
O’Neil, Brian J.
Sanchez, Leon D. http://orcid.org/0000-0002-8807-0913
Joormann, Jutta
Pizzagalli, Diego A. http://orcid.org/0000-0002-7772-1143
Sheridan, John F.
Harte, Steven E.
Kessler, Ronald C. http://orcid.org/0000-0003-4831-2305
Koenen, Karestan C. http://orcid.org/0000-0003-2978-7655
McLean, Samuel A. http://orcid.org/0000-0001-9482-3582
Ressler, Kerry J. http://orcid.org/0000-0002-5158-1103
Stevens, Jennifer S. http://orcid.org/0000-0003-4674-0314
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K01MH121653, U01MH110926)
US Army MRMC, One Mind, The Mayday Fund
Article History
Received: 10 July 2023
Accepted: 25 March 2024
First Online: 22 April 2024
Change Date: 26 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s44220-024-00258-6
Competing interests
: T.C.N. has received research support from NIH, VA and Rainwater Charitable Foundation and consulting income from Jazz Pharmaceuticals. In the past 3 years, G.D.C. has received research funding from the NSF, NIH and LifeBell AI and unrestricted donations from AliveCor Inc., Amazon Research, the Center for Discovery, the Gates Foundation, Google, the Gordon and Betty Moore Foundation, MathWorks, Microsoft Research, Nextsense Inc, One Mind Foundation, the Rett Research Foundation and Samsun Research. G.D.C. has financial interest in AliveCor Inc. and Nextsense Inc. He is also the CTO of MindChild Medical and CSO of LifeBell AI and has ownership in both companies. These relationships are unconnected to the current work. L.T.G. receives funding from the National Institute of Mental Health (R01 MH121617) and am on the board of the Many Brains Project. Her family also has equity in Intelerad Medical Systems, Inc. S.L.R. reports grants from NIH during the conduct of the study; personal fees from the Society of Biological Psychiatry paid roles as secretary, other from Oxford University Press royalties, other from American Psychiatric Publishing Inc. royalties, other from the Veterans Administration per diem for oversight committee and other from Community Psychiatry/Mindpath Health paid board service, including equity outside the submitted work; other from National Association of Behavioral Healthcare for paid Board service; other from Springer Publishing royalties; and Leadership roles on Board or Council for SOBP, the Anxiety and Depression Association of America and the National Network of Depression Centers. S.S. has received funding from the Florida Medical Malpractice Joint Underwriter’s Association Dr. Alvin E. Smith Safety of Healthcare Services Grant, Allergan Foundation, the NIH/NIA-funded Jacksonville Aging Studies Center (JAX-ASCENT; R33AG05654), the Substance Abuse and Mental health Services Administration (1H79TI083101-01) and the Florida Blue Foundation. C.W.J. has no competing interest related to this work, though he has been an investigator on studies funded by AstraZeneca, Vapotherm, Abbott and Ophirex. J.J. receives consulting payments from Janssen Pharmaceuticals. Over the past 3 years, D.A.P. has received consulting fees from Albright Stonebridge Group, Boehringer Ingelheim, Compass Pathways, Concert Pharmaceuticals, Engrail Therapeutics, Neumora Therapeutics (former BlackThorn Therapeutics), Neurocrine Biosciences, Neuroscience Software, Otsuka Pharmaceuticals and Takeda Pharmaceuticals; honoraria from the Psychonomic Society (for editorial work) and Alkermes, and research funding from NIMH, Dana Foundation, Brain and Behavior Research Foundation and Millennium Pharmaceuticals. In addition, he has received stock option from Neumora Therapeutics (former BlackThorn Therapeutics), Compass Pathways, Engrail Therapeutics, and Neuroscience Software. S.E.H. has no competing interest related to this work, though in the past 3 years he has received research funding from Aptinyx and Arbor Medical Innovations and consulting payments from Aptinyx, heron Therapeutics and Eli Lilly. In the past 3 years, R.C.K. was a consultant for Cambridge Health Alliance, Canandaigua VA Medical Center, Holmusk, Partners Healthcare, Inc., RallyPoint Networks, Inc. and Sage Therapeutics. He has stock options in Cerebral Inc., Mirah, PYM and Roga Sciences. K.C.K’s research has been supported by the Robert Wood Johnson Foundation, the Kaiser Family Foundation, the Harvard Center on the Developing Child, Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard, the NIH, One Mind, The Anonymous Foundation and Cohen Veterans Bioscience. She has been a paid consultant for Baker Hostetler, Discovery Vitality and the Department of Justice. She has been a paid external reviewer for the Chan Zuckerberg Foundation, the University of Cape Town and Capita Ireland. She has had paid speaking engagements in the past 3 years with the American Psychological Association, European Central Bank. Sigmund Freud University—Milan, Cambridge Health Alliance and Coverys. She receives royalties from Guilford Press and Oxford University Press. S.A.M. served as a consultant for Walter Reed Army Institute for Research and for Arbor Medical Innovations. K.J.R. has performed scientific consultation for Bioxcel, Bionomics, Acer and Jazz Pharm; serves on Scientific Advisory Boards for Sage, Boehringer Ingelheim, Senseye and the Brain Research Foundation; and has received sponsored research support from Alto Neuroscience. The other authors declare no competing interests.